openPR Logo
Press release

Gastrointestinal Stromal Tumor (GIST) Market 2025: Growth, Applications, Innovations and Business Outlook by 2032 | Novartis AG, Pfizer Inc., Bayer AG, Roche Holding AG

05-05-2025 01:25 PM CET | Health & Medicine

Press release from: CoherentMI

Gastrointestinal Stromal Tumor (GIST) Market

Gastrointestinal Stromal Tumor (GIST) Market

The gastrointestinal stromal tumor (GIST) market is estimated to be valued at USD 1.32 Bn in 2025 and is expected to reach USD 2.54 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.

A new report from CoherentMI, titled "Gastrointestinal Stromal Tumor (GIST) Market 2025-2032," offers an in-depth examination of the industry, including valuable insights into the Gastrointestinal Stromal Tumor (GIST) Market's performance. The report covers competitor dynamics, regional trends and the latest technological developments shaping the market.

The Gastrointestinal Stromal Tumor (GIST) Market has experienced significant growth in recent years, driven by factors such as increasing product demand, a broadening customer base, and advancements in technology. The report highlights key elements of the market, including its size, emerging trends, growth drivers, challenges, competitive landscape and future growth potential.

Get Latest Sample Report at: https://www.coherentmi.com/industry-reports/gastrointestinal-stromal-tumor-gist-market/request-sample

Key Players Analysis Report:

Novartis AG
Pfizer Inc.
Bayer AG
Roche Holding AG
Eli Lilly and Company

Global Gastrointestinal Stromal Tumor (GIST) Market Segments:

By Product

Marketed Drugs
Phase III Pipeline Drugs

By Drug Category

Tyrosine Kinase Inhibitors (TKIs)
Chemotherapy
Immunotherapy

By Route of Administration

Oral
Intravenous

Get the Sample Copy of the Research Report at: https://www.coherentmi.com/industry-reports/gastrointestinal-stromal-tumor-gist-market/request-sample

Market Scope and Growth Analysis:

This expansion is Gastrointestinal Stromal Tumor (GIST) by increasing demand across diverse industries, advancements in technology, and the globalization of trade and supply chains. The market is poised for further growth, driven by innovation and the adoption of sustainable practices. At the beginning of the development of this research report, a summary of the Gastrointestinal Stromal Tumor (GIST) Market is provided, along with definitions, applications, new product launches, developments, hurdles, and geographic considerations. Rising demand across several different industries is expected to fuel the industry's rapid growth. The study Gastrointestinal Stromal Tumor (GIST) market research report looks at key aspects as well as current industry trends. An additional feature is a graphical summary of significant organizations that highlights their market presence, effective marketing methods, and most recent developments in both historical and contemporary contexts.

Competitive Landscape Analysis:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. Additionally, the report features detailed profiles of all major companies in the Gastrointestinal Stromal Tumor (GIST) Market.

Key Metrics & Market Overview for Gastrointestinal Stromal Tumor (GIST):

The market for Gastrointestinal Stromal Tumor (GIST) is evolving rapidly, driven by technological advancements, changing consumer preferences and industry-specific innovations. This analysis provides a comprehensive overview of market size, key drivers, challenges, and emerging trends shaping the industry. It also covers competitive dynamics, highlighting major players, their strategies, and market positioning. Regional and global insights are explored to assess demand fluctuations, investment opportunities, and regulatory impacts across different markets. Additionally, the study offers data-driven forecasts and strategic recommendations to help businesses navigate future market developments effectively. By leveraging key analytics, stakeholders can gain valuable insights into growth opportunities and potential risks, ensuring informed decision-making in this dynamic landscape.

Here is a Comprehensive Overview of Data Report:

↣ This report presents a detailed analysis of key data points that define the current market landscape and future trends.
↣ It includes insights on market size, growth projections and segmentation, along with an in-depth review of industry drivers, challenges and opportunities.
↣ Competitive analysis highlights major players, their strategies and market positioning, while regional insights provide a comprehensive view of geographic variations in demand and investment potential.
↣ Additionally, consumer behavior trends, pricing analysis and regulatory impacts are explored to offer a well-rounded perspective. These essential data points equip businesses and stakeholders with the critical information needed for informed decision-making and strategic planning.

Key Reasons for Buying the Global Gastrointestinal Stromal Tumor (GIST) Report:

✅ Comprehensive Market Insights - Gain a deep understanding of market size, trends and growth opportunities.
✅Competitive Intelligence - Analyze key players, their strategies and market positioning to stay ahead of the competition.
✅ Data-Driven Decision Making - Leverage detailed analytics and forecasts for strategic business planning.
✅Industry Trends & Innovations - Stay updated on emerging trends, technological advancements and market disruptions.
✅ Regional & Global Perspectives - Understand market dynamics across different regions for better expansion strategies.
✅ Risk Assessment & Mitigation - Identify potential challenges and develop strategies to minimize risks.
✅Regulatory & Policy Insights - Stay compliant with industry regulations and understand their impact on market operations.
✅ Investment & Business Opportunities - Discover new revenue streams, partnerships and market entry strategies.
✅ Customer & Consumer Analysis - Understand buyer behavior, preferences, and demand patterns.
✅ Strategic Recommendations - Receive expert insights and actionable recommendations for sustainable growth.

Enhance Your Market Strategy - Purchase the Full Report At: https://www.coherentmi.com/industry-reports/gastrointestinal-stromal-tumor-gist-market/buynow

Major Points from Table of Contents:

1 Study Coverage
2 Executive Summary
3 Market Size by Manufacturers
4 Gastrointestinal Stromal Tumor (GIST) Production by Regions
5 Gastrointestinal Stromal Tumor (GIST) Consumption by Regions
6 Market Size by Type
7 Market Size by Application
8 Manufacturers Profiles
9 Production Forecasts
10 Consumption Forecast
11 Value Chain and Sales Channels Analysis
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
13 Key Findings in the Global Gastrointestinal Stromal Tumor (GIST) Study
14 Appendix

Author of this Marketing PR:

Money Singh is a seasoned PR writer with over four years of experience in the market research sector. Known for her strong SEO background, she skillfully blends SEO strategies with insightful content. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.

📞 Contact Us:
Mr. Shah
CoherentMI,
U.S.: +1-650-918-5898
U.K: +44-020-8133-4027
Australia: +61-2-4786-0457
INDIA: +91-848-285-0837
Email: sales@coherentmi.com
Website: https://www.coherentmi.com

About CoherentMI:
At CoherentMI, we are a leading global market intelligence company dedicated to providing comprehensive insights, analysis, and strategic solutions to empower businesses and organizations worldwide. Moreover, CoherentMI is a subsidiary of Coherent Market Insights Pvt Ltd., which is a market intelligence and consulting organization that helps businesses in critical business decisions. With our cutting-edge technology and experienced team of industry experts, we deliver actionable intelligence that helps our clients make informed decisions and stay ahead in today's rapidly changing business landscape.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastrointestinal Stromal Tumor (GIST) Market 2025: Growth, Applications, Innovations and Business Outlook by 2032 | Novartis AG, Pfizer Inc., Bayer AG, Roche Holding AG here

News-ID: 3999321 • Views:

More Releases from CoherentMI

How the Autosomal Dominant Polycystic Kidney Disease Market Will Evolve by 2032 - Growth, Segments, and Revenue Trends| Otsuka Pharmaceutical, Reata Pharmaceuticals
How the Autosomal Dominant Polycystic Kidney Disease Market Will Evolve by 2032 …
The latest report on the "Autosomal Dominant Polycystic Kidney Disease Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores
What's Driving the Future of the Ocular Hypertension Market? Insights, Forecasts, and Emerging Frontiers |Nicox, Qlaris Bio, TheratOcular Biotek Co.Ltd.
What's Driving the Future of the Ocular Hypertension Market? Insights, Forecasts …
The latest report on the "Ocular Hypertension Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores critical factors such
From Now to 2032: Unpacking the Epithelioid Sarcoma Market's Evolution, Opportunities, and Key Trends |Epizyme, Eli Lilly and Company, Pfizer, Merck Sharp & Dohme
From Now to 2032: Unpacking the Epithelioid Sarcoma Market's Evolution, Opportun …
The most recent in-depth analysis from CoherentMI offers a comprehensive global perspective on the evolving Epithelioid Sarcoma Market, equipping industry stakeholders with data-backed insights into shifting market dynamics, innovation cycles, and emerging business models. This report serves as a trusted roadmap for organizations navigating a landscape shaped by increasing competition, technological disruption, and fluctuating demand across geographies. From strategic positioning to investment trends, the study provides clarity on both micro
A Look Into the Future: Clear Cell Ovarian Cancer Market Set for Disruption and Growth Through 2032 |Genentech, GlaxoSmithKline, Clovis Oncology, AstraZeneca
A Look Into the Future: Clear Cell Ovarian Cancer Market Set for Disruption and …
The latest report on the "Clear Cell Ovarian Cancer Market" by CoherentMI delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and credibility. It explores critical

All 5 Releases


More Releases for GIST

Benchmark Gensuite & GIST Impact Announce Partnership To Bring Unprecedented Cla …
Benchmark Gensuite, a leading provider of cloud-based Environmental, Health, Safety (EHS), and Sustainability software solutions, and GIST Impact, a market-leading impact data and analytics provider, today announced a strategic partnership to deliver comprehensive sustainability management and reporting capabilities to global organizations. This collaboration brings together Benchmark Gensuite's robust digital platform for EHS and sustainability management with GIST Impact's advanced impact data and analytics expertise. The partnership will empower companies with enhanced
Gastrointestinal Stromal Tumors (GIST) Clinical Trials 2024: FDA Approval, Medic …
(Albany, USA) DelveInsight's, "Gastrointestinal Stromal Tumors Pipeline Insight 2024" report provides comprehensive insights about 25+ companies and 28+ pipeline drugs in Gastrointestinal Stromal Tumors (GIST) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment
Global Market Overview 2024: Gastrointestinal Stromal Tumor (GIST) Treatment Tre …
"The Business Research Company recently released a comprehensive report on the Global Gastrointestinal Stromal Tumor Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The gastrointestinal stromal tumor
Gastrointestinal Stromal Tumor (GIST) Drug Market to see Rapid Growth by 2028
The Gastrointestinal Stromal Tumor (GIST) Drug Market size is expected to grow at an annual average of CAGR 5% during the forecast period (2022-2028). Gastrointestinal stromal tumor (GIST) is recognized as one of the most common mesenchymal tumors worldwide. According to the World Health Organization (WHO), the estimated incidence of gastrointestinal stromal tumors is 14.5 per million people and is prevalent in 129 out of 1 million samples in the
Chatbot Builder Software Market to See Huge Growth by 2027 | Gist, MobileMonkey, …
Global Chatbot Builder Software Market Report 2021 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Chatbot Builder Software Market. Some of the key players profiled in the study are Tars, ChatBot, Gist, MobileMonkey,
YabaLeftOnline NG Presenting the Latest Naija Gist and Nigeria Entertainment New …
YabaLeftOnline NG is a leading online platform in Nigeria that offers a wide variety of news from across the country. The platform displays Naija gist, as well as viral news in Nigeria. On YabaLeftOnline NG, its readers can check out the popular Nigerian music videos, music world’s news, and comedy skits. Whether it is Banky W’s campaign posters being destroyed in Lagos or the latest about BBNaija star Anto, the